25 XP   0   0   10

Episurf Medical AB (publ)
Buy, Hold or Sell?

Let's analyse Episurf together

PenkeI guess you are interested in Episurf Medical AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Episurf Medical AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Episurf Medical AB (publ)

I send you an email if I find something interesting about Episurf Medical AB (publ).

Quick analysis of Episurf (30 sec.)










What can you expect buying and holding a share of Episurf? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.32
Expected worth in 1 year
kr-0.03
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
kr-0.35
Return On Investment
-49.4%

For what price can you sell your share?

Current Price per Share
kr0.71
Expected price per share
kr0.65 - kr0.937
How sure are you?
50%

1. Valuation of Episurf (5 min.)




Live pricePrice per Share (EOD)

kr0.71

Intrinsic Value Per Share

kr-3.84 - kr-2.99

Total Value Per Share

kr-3.52 - kr-2.68

2. Growth of Episurf (5 min.)




Is Episurf growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7m$19m-$8.2m-76.4%

How much money is Episurf making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$1.7m-$385.3k-17.9%
Net Profit Margin-947.2%-1,165.5%--

How much money comes from the company's main activities?

3. Financial Health of Episurf (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#245 / 339

Most Revenue
#295 / 339

Most Profit
#175 / 339

Most Efficient
#299 / 339

What can you expect buying and holding a share of Episurf? (5 min.)

Welcome investor! Episurf's management wants to use your money to grow the business. In return you get a share of Episurf.

What can you expect buying and holding a share of Episurf?

First you should know what it really means to hold a share of Episurf. And how you can make/lose money.

Speculation

The Price per Share of Episurf is kr0.709. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Episurf.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Episurf, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.32. Based on the TTM, the Book Value Change Per Share is kr-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Episurf.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-1.1%-0.01-1.1%-0.01-0.9%-0.01-0.9%-0.01-0.8%
Usd Book Value Change Per Share-0.01-1.1%-0.01-1.1%-0.01-0.9%0.000.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.1%-0.01-1.1%-0.01-0.9%0.000.1%0.000.0%
Usd Price Per Share0.09-0.12-0.21-0.20-1.02-
Price to Earnings Ratio-3.02--3.69--8.18--8.26--73.39-
Price-to-Total Gains Ratio-12.07--14.84--33.69--22.15--291.63-
Price to Book Ratio3.13-2.93-2.97-5.34-57.87-
Price-to-Total Gains Ratio-12.07--14.84--33.69--22.15--291.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0646608
Number of shares15465
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (15465 shares)-123.4410.46
Gains per Year (15465 shares)-493.7441.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-494-50404232
20-987-99808474
30-1481-14920126116
40-1975-19860167158
50-2469-24800209200
60-2962-29740251242
70-3456-34680293284
80-3950-39620335326
90-4444-44560377368
100-4937-49500418410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.054.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%7.033.00.017.5%11.042.01.020.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.054.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%7.033.00.017.5%11.042.01.020.4%

Fundamentals of Episurf

About Episurf Medical AB (publ)

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, Europe, and internationally. It offers Episealer knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome; Epioscopy to identify and visualise femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the foot. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.

Fundamental data was last updated by Penke on 2024-03-30 20:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Episurf Medical AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Episurf earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • A Net Profit Margin of -755.2% means that kr-7.55 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Episurf Medical AB (publ):

  • The MRQ is -755.2%. The company is making a huge loss. -2
  • The TTM is -947.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-755.2%TTM-947.2%+192.0%
TTM-947.2%YOY-1,165.5%+218.3%
TTM-947.2%5Y-1,214.0%+266.8%
5Y-1,214.0%10Y-4,555.5%+3,341.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-755.2%-11.2%-744.0%
TTM-947.2%-19.6%-927.6%
YOY-1,165.5%-14.4%-1,151.1%
5Y-1,214.0%-21.3%-1,192.7%
10Y-4,555.5%-24.8%-4,530.7%
1.1.2. Return on Assets

Shows how efficient Episurf is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • -21.0% Return on Assets means that Episurf generated kr-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Episurf Medical AB (publ):

  • The MRQ is -21.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.0%TTM-17.2%-3.8%
TTM-17.2%YOY-8.8%-8.5%
TTM-17.2%5Y-14.7%-2.5%
5Y-14.7%10Y-16.6%+1.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.0%-4.0%-17.0%
TTM-17.2%-4.5%-12.7%
YOY-8.8%-4.8%-4.0%
5Y-14.7%-4.0%-10.7%
10Y-16.6%-5.2%-11.4%
1.1.3. Return on Equity

Shows how efficient Episurf is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • -25.9% Return on Equity means Episurf generated kr-0.26 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Episurf Medical AB (publ):

  • The MRQ is -25.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.9%TTM-20.8%-5.1%
TTM-20.8%YOY-9.6%-11.2%
TTM-20.8%5Y-18.1%-2.7%
5Y-18.1%10Y-19.7%+1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.9%-3.9%-22.0%
TTM-20.8%-5.6%-15.2%
YOY-9.6%-5.9%-3.7%
5Y-18.1%-6.1%-12.0%
10Y-19.7%-7.1%-12.6%

1.2. Operating Efficiency of Episurf Medical AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Episurf is operating .

  • Measures how much profit Episurf makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • An Operating Margin of -689.7% means the company generated kr-6.90  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Episurf Medical AB (publ):

  • The MRQ is -689.7%. The company is operating very inefficient. -2
  • The TTM is -929.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-689.7%TTM-929.0%+239.3%
TTM-929.0%YOY-1,150.2%+221.3%
TTM-929.0%5Y-1,198.8%+269.9%
5Y-1,198.8%10Y-4,545.4%+3,346.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-689.7%-22.8%-666.9%
TTM-929.0%-17.1%-911.9%
YOY-1,150.2%-13.4%-1,136.8%
5Y-1,198.8%-19.2%-1,179.6%
10Y-4,545.4%-24.0%-4,521.4%
1.2.2. Operating Ratio

Measures how efficient Episurf is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 16.38 means that the operating costs are kr16.38 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Episurf Medical AB (publ):

  • The MRQ is 16.379. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.445. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16.379TTM12.445+3.935
TTM12.445YOY12.502-0.058
TTM12.4455Y13.450-1.006
5Y13.45010Y47.992-34.542
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.3791.428+14.951
TTM12.4451.426+11.019
YOY12.5021.503+10.999
5Y13.4501.440+12.010
10Y47.9921.371+46.621

1.3. Liquidity of Episurf Medical AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Episurf is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.74 means the company has kr3.74 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Episurf Medical AB (publ):

  • The MRQ is 3.736. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.501. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.736TTM5.501-1.766
TTM5.501YOY14.624-9.122
TTM5.5015Y8.965-3.464
5Y8.96510Y9.294-0.328
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7362.787+0.949
TTM5.5012.763+2.738
YOY14.6243.488+11.136
5Y8.9653.617+5.348
10Y9.2943.514+5.780
1.3.2. Quick Ratio

Measures if Episurf is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • A Quick Ratio of 3.45 means the company can pay off kr3.45 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Episurf Medical AB (publ):

  • The MRQ is 3.448. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.316. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.448TTM5.316-1.868
TTM5.316YOY14.373-9.057
TTM5.3165Y8.714-3.399
5Y8.71410Y8.932-0.218
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4481.539+1.909
TTM5.3161.660+3.656
YOY14.3732.139+12.234
5Y8.7142.300+6.414
10Y8.9322.255+6.677

1.4. Solvency of Episurf Medical AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Episurf assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Episurf to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that Episurf assets are financed with 19.0% credit (debt) and the remaining percentage (100% - 19.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Episurf Medical AB (publ):

  • The MRQ is 0.190. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.165. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.165+0.025
TTM0.165YOY0.081+0.084
TTM0.1655Y0.140+0.025
5Y0.14010Y0.124+0.015
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1900.389-0.199
TTM0.1650.386-0.221
YOY0.0810.338-0.257
5Y0.1400.442-0.302
10Y0.1240.460-0.336
1.4.2. Debt to Equity Ratio

Measures if Episurf is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Episurf to the Medical Devices industry mean.
  • A Debt to Equity ratio of 23.4% means that company has kr0.23 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Episurf Medical AB (publ):

  • The MRQ is 0.234. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.199. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.199+0.035
TTM0.199YOY0.089+0.111
TTM0.1995Y0.173+0.026
5Y0.17310Y0.150+0.024
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2340.559-0.325
TTM0.1990.560-0.361
YOY0.0890.478-0.389
5Y0.1730.624-0.451
10Y0.1500.674-0.524

2. Market Valuation of Episurf Medical AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Episurf generates.

  • Above 15 is considered overpriced but always compare Episurf to the Medical Devices industry mean.
  • A PE ratio of -3.02 means the investor is paying kr-3.02 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Episurf Medical AB (publ):

  • The EOD is -2.162. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.018. Based on the earnings, the company is expensive. -2
  • The TTM is -3.686. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.162MRQ-3.018+0.857
MRQ-3.018TTM-3.686+0.668
TTM-3.686YOY-8.184+4.498
TTM-3.6865Y-8.259+4.573
5Y-8.25910Y-73.394+65.135
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.162-1.037-1.125
MRQ-3.018-1.578-1.440
TTM-3.686-2.041-1.645
YOY-8.184-2.971-5.213
5Y-8.259-2.058-6.201
10Y-73.394-1.463-71.931
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Episurf Medical AB (publ):

  • The EOD is -2.162. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.018. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.675. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.162MRQ-3.018+0.857
MRQ-3.018TTM-3.675+0.657
TTM-3.675YOY-7.651+3.976
TTM-3.6755Y-8.520+4.845
5Y-8.52010Y-70.165+61.645
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.162-1.007-1.155
MRQ-3.018-1.544-1.474
TTM-3.675-3.018-0.657
YOY-7.651-6.339-1.312
5Y-8.520-4.928-3.592
10Y-70.165-4.950-65.215
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Episurf is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.13 means the investor is paying kr3.13 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Episurf Medical AB (publ):

  • The EOD is 2.241. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.129. Based on the equity, the company is fair priced.
  • The TTM is 2.926. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.241MRQ3.129-0.888
MRQ3.129TTM2.926+0.203
TTM2.926YOY2.968-0.042
TTM2.9265Y5.340-2.414
5Y5.34010Y57.867-52.527
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.2411.987+0.254
MRQ3.1292.379+0.750
TTM2.9262.444+0.482
YOY2.9683.215-0.247
5Y5.3403.833+1.507
10Y57.8674.163+53.704
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Episurf Medical AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.082-0.088+7%-0.070-14%0.007-1205%0.001-6966%
Book Value Per Share--0.3160.442-28%0.782-60%0.508-38%0.389-19%
Current Ratio--3.7365.501-32%14.624-74%8.965-58%9.294-60%
Debt To Asset Ratio--0.1900.165+15%0.081+134%0.140+36%0.124+52%
Debt To Equity Ratio--0.2340.199+18%0.089+165%0.173+35%0.150+56%
Dividend Per Share----0%-0%-0%-0%
Eps---0.082-0.089+8%-0.072-12%-0.070-14%-0.059-28%
Free Cash Flow Per Share---0.082-0.088+8%-0.076-8%-0.069-16%-0.059-28%
Free Cash Flow To Equity Per Share---0.085-0.091+7%-0.078-9%0.018-585%0.015-649%
Gross Profit Margin--1.0001.080-7%1.035-3%1.023-2%1.011-1%
Intrinsic Value_10Y_max---2.993--------
Intrinsic Value_10Y_min---3.840--------
Intrinsic Value_1Y_max---0.247--------
Intrinsic Value_1Y_min---0.318--------
Intrinsic Value_3Y_max---0.782--------
Intrinsic Value_3Y_min---1.020--------
Intrinsic Value_5Y_max---1.366--------
Intrinsic Value_5Y_min---1.785--------
Market Cap189013728.000-40%264394792.530347158301.466-24%616810162.371-57%585883596.767-55%2983654854.384-91%
Net Profit Margin---7.552-9.472+25%-11.655+54%-12.140+61%-45.555+503%
Operating Margin---6.897-9.290+35%-11.502+67%-11.988+74%-45.454+559%
Operating Ratio--16.37912.445+32%12.502+31%13.450+22%47.992-66%
Pb Ratio2.241-40%3.1292.926+7%2.968+5%5.340-41%57.867-95%
Pe Ratio-2.162+28%-3.018-3.686+22%-8.184+171%-8.259+174%-73.394+2332%
Price Per Share0.709-40%0.9901.299-24%2.314-57%2.197-55%11.191-91%
Price To Free Cash Flow Ratio-2.162+28%-3.018-3.675+22%-7.651+153%-8.520+182%-70.165+2225%
Price To Total Gains Ratio-8.646+28%-12.073-14.836+23%-33.686+179%-22.149+83%-291.634+2316%
Quick Ratio--3.4485.316-35%14.373-76%8.714-60%8.932-61%
Return On Assets---0.210-0.172-18%-0.088-58%-0.147-30%-0.166-21%
Return On Equity---0.259-0.208-20%-0.096-63%-0.181-30%-0.197-24%
Total Gains Per Share---0.082-0.088+7%-0.070-14%0.007-1205%0.001-6966%
Usd Book Value--7706400.00010777560.000-28%19008360.000-59%12362160.000-38%9454389.985-18%
Usd Book Value Change Per Share---0.007-0.008+7%-0.006-14%0.001-1205%0.000-6966%
Usd Book Value Per Share--0.0290.040-28%0.071-60%0.046-38%0.035-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-0.008+8%-0.007-12%-0.006-14%-0.005-28%
Usd Free Cash Flow---1997280.000-2152320.000+8%-1842240.000-8%-1670328.000-16%-1444300.930-28%
Usd Free Cash Flow Per Share---0.007-0.008+8%-0.007-8%-0.006-16%-0.005-28%
Usd Free Cash Flow To Equity Per Share---0.008-0.008+7%-0.007-9%0.002-585%0.001-649%
Usd Market Cap17238051.994-40%24112805.07931660837.094-24%56253086.808-57%53432584.025-55%272109322.720-91%
Usd Price Per Share0.065-40%0.0900.118-24%0.211-57%0.200-55%1.021-91%
Usd Profit---1997280.000-2156880.000+8%-1771560.000-11%-1710456.000-14%-1442213.995-28%
Usd Revenue--264480.000232560.000+14%152760.000+73%152304.000+74%99146.598+167%
Usd Total Gains Per Share---0.007-0.008+7%-0.006-14%0.001-1205%0.000-6966%
 EOD+3 -5MRQTTM+17 -17YOY+5 -295Y+6 -2810Y+7 -27

3.2. Fundamental Score

Let's check the fundamental score of Episurf Medical AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.162
Price to Book Ratio (EOD)Between0-12.241
Net Profit Margin (MRQ)Greater than0-7.552
Operating Margin (MRQ)Greater than0-6.897
Quick Ratio (MRQ)Greater than13.448
Current Ratio (MRQ)Greater than13.736
Debt to Asset Ratio (MRQ)Less than10.190
Debt to Equity Ratio (MRQ)Less than10.234
Return on Equity (MRQ)Greater than0.15-0.259
Return on Assets (MRQ)Greater than0.05-0.210
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Episurf Medical AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.766
Ma 20Greater thanMa 500.742
Ma 50Greater thanMa 1000.818
Ma 100Greater thanMa 2000.927
OpenGreater thanClose0.720
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets104,300
Total Liabilities19,800
Total Stockholder Equity84,500
 As reported
Total Liabilities 19,800
Total Stockholder Equity+ 84,500
Total Assets = 104,300

Assets

Total Assets104,300
Total Current Assets65,000
Long-term Assets39,300
Total Current Assets
Cash And Cash Equivalents 57,900
Net Receivables 2,100
Inventory 3,700
Other Current Assets 1,300
Total Current Assets  (as reported)65,000
Total Current Assets  (calculated)65,000
+/-0
Long-term Assets
Property Plant Equipment 5,600
Intangible Assets 33,600
Long-term Assets Other 100
Long-term Assets  (as reported)39,300
Long-term Assets  (calculated)39,300
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,400
Long-term Liabilities2,400
Total Stockholder Equity84,500
Total Current Liabilities
Short-term Debt 2,900
Accounts payable 6,100
Other Current Liabilities 8,400
Total Current Liabilities  (as reported)17,400
Total Current Liabilities  (calculated)17,400
+/- 0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,300
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)2,400
Long-term Liabilities  (calculated)2,400
+/-0
Total Stockholder Equity
Common Stock80,200
Retained Earnings -680,200
Accumulated Other Comprehensive Income -300
Other Stockholders Equity 684,800
Total Stockholder Equity (as reported)84,500
Total Stockholder Equity (calculated)84,500
+/-0
Other
Capital Stock80,200
Cash and Short Term Investments 57,900
Common Stock Shares Outstanding 267,065
Current Deferred Revenue0
Liabilities and Stockholders Equity 104,300
Net Debt -52,700
Net Invested Capital 84,500
Net Working Capital 47,600
Property Plant and Equipment Gross 5,600
Short Long Term Debt Total 5,200



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
> Total Assets 
0
0
0
11,273
10,191
56,083
52,443
50,545
39,044
35,068
32,613
27,912
22,821
72,457
81,972
76,423
68,089
60,408
49,918
43,238
36,253
25,969
130,401
118,200
104,417
87,515
73,052
60,305
146,668
123,099
107,905
93,286
81,100
70,400
55,900
54,800
48,400
93,600
75,300
57,600
119,800
152,300
137,200
185,400
167,700
151,400
134,600
270,600
255,200
236,700
217,500
197,200
176,100
154,800
128,300
104,300
104,300128,300154,800176,100197,200217,500236,700255,200270,600134,600151,400167,700185,400137,200152,300119,80057,60075,30093,60048,40054,80055,90070,40081,10093,286107,905123,099146,66860,30573,05287,515104,417118,200130,40125,96936,25343,23849,91860,40868,08976,42381,97272,45722,82127,91232,61335,06839,04450,54552,44356,08310,19111,273000
   > Total Current Assets 
0
0
0
7,630
5,443
49,428
44,135
40,478
37,033
32,917
30,067
25,265
19,513
68,888
77,410
71,209
62,368
54,413
43,871
36,917
28,972
18,171
121,292
106,730
92,437
75,028
60,875
47,349
132,314
108,187
92,765
77,028
62,800
50,800
35,500
33,600
18,900
64,700
47,100
30,200
92,800
126,200
111,700
160,300
143,400
127,400
109,600
244,400
223,000
203,500
183,800
161,000
136,500
114,000
87,500
65,000
65,00087,500114,000136,500161,000183,800203,500223,000244,400109,600127,400143,400160,300111,700126,20092,80030,20047,10064,70018,90033,60035,50050,80062,80077,02892,765108,187132,31447,34960,87575,02892,437106,730121,29218,17128,97236,91743,87154,41362,36871,20977,41068,88819,51325,26530,06732,91737,03340,47844,13549,4285,4437,630000
       Cash And Cash Equivalents 
0
0
0
7,016
5,177
48,680
43,653
39,613
36,143
32,023
28,861
23,075
17,870
67,553
75,619
68,869
59,444
51,290
41,398
34,490
25,586
14,513
117,796
103,961
88,790
71,586
56,134
42,300
127,321
103,138
87,541
71,279
56,800
44,900
29,900
28,300
13,500
59,000
42,600
25,300
86,000
121,200
106,600
155,000
137,400
120,700
103,800
237,900
217,400
197,100
178,200
155,300
130,200
107,000
80,700
57,900
57,90080,700107,000130,200155,300178,200197,100217,400237,900103,800120,700137,400155,000106,600121,20086,00025,30042,60059,00013,50028,30029,90044,90056,80071,27987,541103,138127,32142,30056,13471,58688,790103,961117,79614,51325,58634,49041,39851,29059,44468,86975,61967,55317,87023,07528,86132,02336,14339,61343,65348,6805,1777,016000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,565
1,847
2,270
1,666
3,662
2,600
2,200
2,500
3,400
800
900
600
3,000
2,800
1,600
2,000
3,400
2,300
2,900
2,400
4,000
1,800
2,500
2,000
3,900
4,200
2,600
4,400
2,100
2,1004,4002,6004,2003,9002,0002,5001,8004,0002,4002,9002,3003,4002,0001,6002,8003,0006009008003,4002,5002,2002,6003,6621,6662,2701,8473,565000000000000000000000000000
       Other Current Assets 
0
0
0
614
266
748
483
865
890
894
1,206
1,776
1,231
763
1,180
1,801
2,132
1,920
1,234
953
1,891
2,229
2,244
1,615
2,433
2,251
3,662
3,943
3,764
3,913
3,781
4,067
4,400
4,000
3,800
3,800
3,900
4,300
2,800
3,100
4,900
3,100
3,400
3,300
4,200
4,900
3,800
4,600
4,000
4,500
3,800
-100
100
1,800
-100
1,300
1,300-1001,800100-1003,8004,5004,0004,6003,8004,9004,2003,3003,4003,1004,9003,1002,8004,3003,9003,8003,8004,0004,4004,0673,7813,9133,7643,9433,6622,2512,4331,6152,2442,2291,8919531,2341,9202,1321,8011,1807631,2311,7761,206894890865483748266614000
   > Long-term Assets 
0
0
0
3,643
4,749
6,655
8,307
10,067
2,011
2,151
2,546
2,647
3,308
3,570
4,562
5,213
5,721
5,994
6,048
6,322
7,281
7,798
9,110
11,470
11,979
12,488
12,177
12,956
14,355
14,913
15,139
16,258
18,300
19,600
20,400
21,200
29,500
28,900
28,200
27,500
27,000
26,100
25,500
25,100
24,300
23,900
25,000
26,300
32,100
33,100
33,700
36,200
39,600
40,800
40,800
39,300
39,30040,80040,80039,60036,20033,70033,10032,10026,30025,00023,90024,30025,10025,50026,10027,00027,50028,20028,90029,50021,20020,40019,60018,30016,25815,13914,91314,35512,95612,17712,48811,97911,4709,1107,7987,2816,3226,0485,9945,7215,2134,5623,5703,3082,6472,5462,1512,01110,0678,3076,6554,7493,643000
       Property Plant Equipment 
0
0
0
17
21
19
46
100
195
189
203
121
113
120
402
519
509
477
460
427
394
362
330
424
405
432
404
382
369
325
279
246
200
200
100
100
7,700
7,100
6,600
6,000
5,600
5,000
4,400
3,800
3,300
2,800
3,100
3,200
7,200
6,600
6,000
6,900
8,600
8,600
7,200
5,600
5,6007,2008,6008,6006,9006,0006,6007,2003,2003,1002,8003,3003,8004,4005,0005,6006,0006,6007,1007,70010010020020024627932536938240443240542433036239442746047750951940212011312120318919510046192117000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,271
8,967
9,150
9,091
14,682
18,100
19,400
20,200
21,100
21,800
21,800
21,700
21,400
21,400
21,100
21,000
20,800
20,500
20,600
21,400
23,100
24,900
26,500
27,600
29,400
31,000
32,100
33,600
33,600
33,60033,60032,10031,00029,40027,60026,50024,90023,10021,40020,60020,50020,80021,00021,10021,40021,40021,70021,80021,80021,10020,20019,40018,10014,6829,0919,1508,9678,271000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,302
5,018
5,437
5,769
6,756
8,700
9,100
9,300
9,500
9,500
9,100
8,500
7,900
7,600
7,200
7,200
6,700
6,300
47,900
7,300
8,800
100
100
13,600
15,900
0
100
0
0
00100015,90013,6001001008,8007,30047,9006,3006,7007,2007,2007,6007,9008,5009,1009,5009,5009,3009,1008,7006,7565,7695,4375,0184,302000000000000000000000000000
> Total Liabilities 
0
0
0
1,535
1,169
4,608
2,462
2,044
2,585
2,024
2,305
3,520
3,758
8,806
4,214
4,809
4,562
6,201
3,014
4,389
4,936
5,437
6,303
8,266
6,127
5,135
5,738
11,606
18,415
8,660
6,860
7,714
9,000
13,100
9,800
10,000
17,800
15,800
15,100
16,200
19,000
13,900
14,000
15,900
14,900
15,100
13,800
17,800
18,400
18,500
16,500
19,500
21,200
27,900
21,900
19,800
19,80021,90027,90021,20019,50016,50018,50018,40017,80013,80015,10014,90015,90014,00013,90019,00016,20015,10015,80017,80010,0009,80013,1009,0007,7146,8608,66018,41511,6065,7385,1356,1278,2666,3035,4374,9364,3893,0146,2014,5624,8094,2148,8063,7583,5202,3052,0242,5852,0442,4624,6081,1691,535000
   > Total Current Liabilities 
0
0
0
1,535
1,169
4,608
2,462
2,044
2,585
2,024
2,305
3,520
3,758
8,806
4,214
4,809
4,562
6,201
3,014
4,389
4,936
5,437
6,303
8,266
6,127
5,135
5,735
11,596
18,414
8,653
6,834
7,694
8,900
13,000
9,800
9,900
12,700
11,200
11,100
12,700
15,800
11,300
11,700
13,900
13,100
13,400
12,000
14,200
12,400
13,700
12,500
14,700
16,000
23,000
18,300
17,400
17,40018,30023,00016,00014,70012,50013,70012,40014,20012,00013,40013,10013,90011,70011,30015,80012,70011,10011,20012,7009,9009,80013,0008,9007,6946,8348,65318,41411,5965,7355,1356,1278,2666,3035,4374,9364,3893,0146,2014,5624,8094,2148,8063,7583,5202,3052,0242,5852,0442,4624,6081,1691,535000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,159
0
0
0
0
0
0
4,300
2,800
4,600
2,300
2,300
2,400
2,400
2,300
2,400
2,400
2,400
2,300
2,300
2,100
2,200
2,200
2,100
2,500
3,100
3,100
3,200
2,900
2,9003,2003,1003,1002,5002,1002,2002,2002,1002,3002,3002,4002,4002,4002,3002,4002,4002,3002,3004,6002,8004,3000000001,159000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,300000000000000000000000000000000000000
       Accounts payable 
0
0
0
647
323
3,325
1,040
1,128
1,326
954
839
1,615
1,483
2,386
1,307
1,981
2,181
3,203
1,566
1,090
1,873
2,475
1,040
1,788
2,721
2,214
2,183
6,234
8,960
1,744
2,748
2,461
3,500
3,000
1,600
1,600
3,600
3,200
4,100
6,000
8,100
4,100
3,700
5,400
6,000
5,200
3,700
5,900
4,900
4,500
5,000
4,400
5,600
7,200
5,400
6,100
6,1005,4007,2005,6004,4005,0004,5004,9005,9003,7005,2006,0005,4003,7004,1008,1006,0004,1003,2003,6001,6001,6003,0003,5002,4612,7481,7448,9606,2342,1832,2142,7211,7881,0402,4751,8731,0901,5663,2032,1811,9811,3072,3861,4831,6158399541,3261,1281,0403,325323647000
       Other Current Liabilities 
0
0
0
888
845
1,283
1,422
916
1,259
1,070
1,466
1,905
2,275
6,421
2,907
2,828
2,381
2,998
1,447
3,299
3,063
2,962
5,263
6,478
3,406
2,921
3,552
4,202
9,454
6,909
4,086
5,233
5,400
10,000
3,900
5,500
4,500
5,700
4,700
4,300
5,300
4,900
5,600
6,100
4,700
5,900
6,000
6,200
5,300
7,000
5,400
7,800
7,300
1,900
1,700
8,400
8,4001,7001,9007,3007,8005,4007,0005,3006,2006,0005,9004,7006,1005,6004,9005,3004,3004,7005,7004,5005,5003,90010,0005,4005,2334,0866,9099,4544,2023,5522,9213,4066,4785,2632,9623,0633,2991,4472,9982,3812,8282,9076,4212,2751,9051,4661,0701,2599161,4221,283845888000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
10
1
7
25
20
100
100
0
100
5,100
4,600
4,000
3,500
3,200
2,600
2,300
2,000
1,800
1,700
1,800
3,600
6,000
4,800
4,000
4,800
5,200
4,900
3,600
2,400
2,4003,6004,9005,2004,8004,0004,8006,0003,6001,8001,7001,8002,0002,3002,6003,2003,5004,0004,6005,100100010010020257110300000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,100
1,500
900
500
500
800
4,600
4,100
3,600
3,800
4,800
4,800
3,400
0
03,4004,8004,8003,8003,6004,1004,6008005005009001,5002,100000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
1
7
25
20
100
100
0
100
0
0
0
-100
0
0
200
500
900
1,200
1,300
2,800
1,400
700
400
1,000
0
100
0
0
0010001,0004007001,4002,8001,3001,20090050020000-100000100010010020257110000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,302
5,018
5,437
5,769
6,756
8,700
9,100
9,300
9,500
9,500
9,100
8,600
8,000
7,600
7,200
7,100
6,700
6,400
6,700
7,300
9,000
11,000
12,600
13,600
15,900
0
19,000
0
0
0019,000015,90013,60012,60011,0009,0007,3006,7006,4006,7007,1007,2007,6008,0008,6009,1009,5009,5009,3009,1008,7006,7565,7695,4375,0184,302000000000000000000000000000
> Total Stockholder Equity
0
0
0
9,737
9,022
51,475
49,981
48,501
36,459
33,043
30,309
24,392
19,063
63,651
77,758
71,614
63,528
54,207
46,905
38,850
31,316
20,532
124,099
109,935
98,289
82,380
67,314
48,699
128,253
114,440
101,045
85,571
72,100
57,300
46,100
44,800
30,600
77,800
60,200
41,400
100,800
138,400
123,200
169,500
152,800
136,300
120,800
252,800
236,800
218,200
201,000
177,700
154,900
126,900
106,400
84,500
84,500106,400126,900154,900177,700201,000218,200236,800252,800120,800136,300152,800169,500123,200138,400100,80041,40060,20077,80030,60044,80046,10057,30072,10085,571101,045114,440128,25348,69967,31482,38098,289109,935124,09920,53231,31638,85046,90554,20763,52871,61477,75863,65119,06324,39230,30933,04336,45948,50149,98151,4759,0229,737000
   Common Stock
0
0
0
640
640
1,920
1,920
1,920
1,920
1,920
1,920
1,920
1,920
2,263
2,386
2,386
2,387
2,387
2,387
2,387
2,387
2,392
4,789
4,789
4,789
4,789
4,789
4,789
9,173
9,173
9,173
9,173
9,200
9,200
9,300
10,500
10,500
27,300
27,300
27,300
43,300
55,600
55,600
66,700
66,700
66,700
66,700
80,000
80,000
80,100
80,100
80,100
80,100
80,200
80,200
80,200
80,20080,20080,20080,10080,10080,10080,10080,00080,00066,70066,70066,70066,70055,60055,60043,30027,30027,30027,30010,50010,5009,3009,2009,2009,1739,1739,1739,1734,7894,7894,7894,7894,7894,7892,3922,3872,3872,3872,3872,3872,3862,3862,2631,9201,9201,9201,9201,9201,9201,9201,920640640000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income -300-200-200-2000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
11,656
11,656
52,114
50,619
49,140
49,896
53,598
53,598
53,598
53,598
104,452
123,211
124,411
124,560
124,560
124,560
124,560
124,560
125,155
237,233
237,218
237,269
237,834
237,802
105,577
666
666
642
330,956
400
332,100
333,600
346,400
346,800
396,100
395,300
394,200
455,500
494,800
494,800
546,000
545,800
545,800
545,900
684,100
683,300
684,300
684,400
684,600
684,600
684,600
686,100
684,800
684,800686,100684,600684,600684,600684,400684,300683,300684,100545,900545,800545,800546,000494,800494,800455,500394,200395,300396,100346,800346,400333,600332,100400330,956642666666105,577237,802237,834237,269237,218237,233125,155124,560124,560124,560124,560124,560124,411123,211104,45253,59853,59853,59853,59849,89649,14050,61952,11411,65611,656000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue10,300
Cost of Revenue-104,700
Gross Profit-94,400-94,400
 
Operating Income (+$)
Gross Profit-94,400
Operating Expense-2,700
Operating Income-97,100-97,100
 
Operating Expense (+$)
Research Development8,300
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,7008,300
 
Net Interest Income (+$)
Interest Income600
Interest Expense-900
Other Finance Cost-200
Net Interest Income-100
 
Pretax Income (+$)
Operating Income-97,100
Net Interest Income-100
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-94,600-99,600
EBIT - interestExpense = -98,000
-94,600
-93,900
Interest Expense900
Earnings Before Interest and Taxes (EBIT)-97,100-93,700
Earnings Before Interest and Taxes (EBITDA)-91,100
 
After tax Income (+$)
Income Before Tax-94,600
Tax Provision-200
Net Income From Continuing Ops-96,600-94,800
Net Income-94,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses107,400
Total Other Income/Expenses Net2,500100
 

Technical Analysis of Episurf
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Episurf. The general trend of Episurf is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Episurf's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Episurf Medical AB (publ).

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.878 < 0.904 < 0.937.

The bearish price targets are: 0.696 > 0.65.

Tweet this
Episurf Medical AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Episurf Medical AB (publ). The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Episurf Medical AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Episurf Medical AB (publ). The current macd is -0.02871094.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Episurf price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Episurf. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Episurf price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Episurf Medical AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartEpisurf Medical AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Episurf Medical AB (publ). The current adx is 8.79477096.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Episurf shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Episurf Medical AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Episurf Medical AB (publ). The current sar is 0.79557358.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Episurf Medical AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Episurf Medical AB (publ). The current rsi is 41.77. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Episurf Medical AB (publ) Daily Relative Strength Index (RSI) ChartEpisurf Medical AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Episurf Medical AB (publ). The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Episurf price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Episurf Medical AB (publ) Daily Stochastic Oscillator ChartEpisurf Medical AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Episurf Medical AB (publ). The current cci is -91.13394216.

Episurf Medical AB (publ) Daily Commodity Channel Index (CCI) ChartEpisurf Medical AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Episurf Medical AB (publ). The current cmo is -18.08445841.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Episurf Medical AB (publ) Daily Chande Momentum Oscillator (CMO) ChartEpisurf Medical AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Episurf Medical AB (publ). The current willr is -84.92462312.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Episurf Medical AB (publ) Daily Williams %R ChartEpisurf Medical AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Episurf Medical AB (publ).

Episurf Medical AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Episurf Medical AB (publ). The current atr is 0.06005866.

Episurf Medical AB (publ) Daily Average True Range (ATR) ChartEpisurf Medical AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Episurf Medical AB (publ). The current obv is -15,087,972.

Episurf Medical AB (publ) Daily On-Balance Volume (OBV) ChartEpisurf Medical AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Episurf Medical AB (publ). The current mfi is 35.58.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Episurf Medical AB (publ) Daily Money Flow Index (MFI) ChartEpisurf Medical AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Episurf Medical AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Episurf Medical AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Episurf Medical AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.766
Ma 20Greater thanMa 500.742
Ma 50Greater thanMa 1000.818
Ma 100Greater thanMa 2000.927
OpenGreater thanClose0.720
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Episurf with someone you think should read this too:
  • Are you bullish or bearish on Episurf? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Episurf? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Episurf Medical AB (publ)

I send you an email if I find something interesting about Episurf Medical AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about Episurf Medical AB (publ).

Receive notifications about Episurf Medical AB (publ) in your mailbox!